Trials / Conditions / Myelosuppression Adult
Myelosuppression Adult
6 registered clinical trials studyying Myelosuppression Adult — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients NCT06665737 | Department of Medical Services Ministry of Public Health of Thailand | Phase 4 |
| Terminated | Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy T NCT04887831 | G1 Therapeutics, Inc. | Phase 2 |
| Terminated | Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer NCT04607668 | G1 Therapeutics, Inc. | Phase 3 |
| Unknown | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients NCT03793205 | Lei Li | Phase 4 |
| Unknown | Long-acting G-CSF for Febrile Neutropenia NCT03740464 | Lei Li | Phase 3 |
| Approved For Marketing | Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer NCT04504513 | G1 Therapeutics, Inc. | — |